PubMed:15461822 / 1486-1626
Annnotations
LitCoin-entities
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
1123 | 4-9 | OrganismTaxon | denotes | rDEN2 | NCBITaxon:11060 |
1124 | 9-16 | SequenceVariant | denotes | Delta30 | c|DEL||30 |
1125 | 21-26 | OrganismTaxon | denotes | rDEN2 | NCBITaxon:11060 |
1126 | 26-38 | SequenceVariant | denotes | Delta30-4995 | c|DEL|4995|30 |
1127 | 83-89 | OrganismTaxon | denotes | humans | NCBITaxon:9606 |
1128 | 125-131 | DiseaseOrPhenotypicFeature | denotes | dengue | MESH:D003715 |
LitCoin-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T15 | 0-140 | Sentence | denotes | The rDEN2Delta30 and rDEN2Delta30-4995 viruses can be considered for evaluation in humans and for inclusion in a tetravalent dengue vaccine. |
LitCoin-entities-OrganismTaxon-PD
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T24 | 39-46 | OrganismTaxon | denotes | viruses | NCBItxid:10239 |
T25 | 83-89 | OrganismTaxon | denotes | humans | NCBItxid:9605 |
LitCoin-SeqVar
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T8 | 9-16 | SequenceVariant | denotes | Delta30 |
T9 | 26-38 | SequenceVariant | denotes | Delta30-4995 |
LitCoin-GeneOrGeneProduct-v0
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T33 | 108-112 | GeneOrGeneProduct | denotes | in a |
LitCoin-Disease-MeSH
Id | Subject | Object | Predicate | Lexical cue | originalLabel |
---|---|---|---|---|---|
T5 | 125-131 | DiseaseOrPhenotypicFeature | denotes | dengue | D003715 |
LitCoin_Mondo_095
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T9 | 47-50 | DiseaseOrPhenotypicFeature | denotes | can | 0012833 |
LitCoin-MeSH-Disease-2
Id | Subject | Object | Predicate | Lexical cue | ID: |
---|---|---|---|---|---|
T9 | 125-131 | DiseaseOrPhenotypicFeature | denotes | dengue | D003715 |
LitCoin-Chemical-MeSH-CHEBI
Id | Subject | Object | Predicate | Lexical cue | ID: |
---|---|---|---|---|---|
T10 | 125-139 | ChemicalEntity | denotes | dengue vaccine | D053059 |
LitCoin-NCBITaxon-2
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T25 | 39-46 | OrganismTaxon | denotes | viruses |
T26 | 83-89 | OrganismTaxon | denotes | humans |
LitCoin-training-merged
Id | Subject | Object | Predicate | Lexical cue | ID: |
---|---|---|---|---|---|
T10 | 125-139 | ChemicalEntity | denotes | dengue vaccine | D053059 |
T26 | 83-89 | OrganismTaxon | denotes | humans | |
T25 | 39-46 | OrganismTaxon | denotes | viruses | |
T68177 | 26-38 | SequenceVariant | denotes | Delta30-4995 | |
T18835 | 9-16 | SequenceVariant | denotes | Delta30 |
Inflammaging
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T15 | 0-140 | Sentence | denotes | The rDEN2Delta30 and rDEN2Delta30-4995 viruses can be considered for evaluation in humans and for inclusion in a tetravalent dengue vaccine. |
T15 | 0-140 | Sentence | denotes | The rDEN2Delta30 and rDEN2Delta30-4995 viruses can be considered for evaluation in humans and for inclusion in a tetravalent dengue vaccine. |
tmVarCorpus
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T8 | 9-16 | DNAMutation:|DEL||30 | denotes | Delta30 |
T9 | 26-33 | DNAMutation:|DEL||30 | denotes | Delta30 |